Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial - Concepedia

Concepedia

Publication | Open Access

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

DOI Full Paper Access

44

Citations

35

References

2023

Year

Mikkel Østergaard, Ronald van Vollenhoven, Anna Rudin, Merete Lund Hetland, Marte Schrumpf Heiberg, Dan Nordström, Michael T. Nurmohamed, Björn Guðbjörnsson, Lykke Midtbøll Ørnbjerg, Pernille Bøyesen,

Annals of the Rheumatic Diseases

References

	Year	Citations

Page 1